We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NOXXON Initiates First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12

News   Nov 03, 2009

 
NOXXON Initiates First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12
 
 
 

RELATED ARTICLES

Probiotic Gives Long-standing Protection Against Childhood Eczema

News

Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life.

READ MORE

Drug Improves Outcomes & Survival Rates in Patients with Bone Marrow Cancer

News

In the largest study of its kind, researchers at Newcastle University have led national research into the treatment of patients with newly diagnosed myeloma. The results, published by The Lancet Oncology, show an improvement for those who received ongoing therapy with a drug called lenalidomide, compared to those not receiving it.

READ MORE

Next Step Towards Replacement Therapy in Type 1 Diabetes

News

Scientists have discovered the signals that determine the fate of immature cells in the pancreas. The research shows that they are very mobile and that their destiny is strongly influenced by their immediate environment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE